Reports and Presentations

The presentation covers HHSC’s Legislative Appropriations Request (LAR) for Fiscal Years 2024-2025. In includes an overview of the agency’s mission and vision, key functions, and organizational structure, as well as key budget drivers and Medicaid & CHIP caseloads. It also provides summaries of HHSC’s LAR and Exceptional Item Requests.

State Medicaid Managed Care Advisory Committee Report to HHSC Executive Commissioner, December 2021

This quarterly report reflects activities and findings of the Data Analytics Unit.

This report provides preliminary findings from the 2019 utilization review of the Managed Care STAR+PLUS review.

This annual report builds on the previous annual report, submitted in January 2019, which provided outcomes related to transitioning children and young adults enrolled in the Medically Dependent Children Program (MDCP) into the STAR Kids capitated managed care program.

The report includes the prescription drug rebate outstanding principal and interest amounts, age of receivables, annual collection rates, billed amounts, dollar value of pricing and utilization adjustments, and dollars collected. This report includes a separate prescription drug rebate collection report for each managed care and fee-for-service rebate program.

Provides information on the State Opioid Response grant received from SAMHSA and the implementation and goals of these funds through the Texas Targeted Opioid Response program.

This annual report to HHSC Executive Commissioner authored by the STAR Kids Advisory Committee outlines identified issues and recommendations for improvements to the STAR Kids Medicaid managed care program.

This report summarizes EQRO activities for FY 2018, September 1, 2017, through August 31, 2018. EQRO activities include performance measurement, performance improvement project validation, encounter data validation, member and provider surveys, and focused studies.

This report examines the frequency of pregnancy-related depression among women with a Medicaid-paid delivery, the frequency of pregnancy-related depression screening by Medicaid and Women's Health providers, the utilization of services and onset of treatment for pregnancy-related depression, and Medicaid costs during fiscal year 2016.